FURIEX PHARMACEUTICALS, INC. Interest Expense
FURIEX PHARMACEUTICALS, INC. reported Interest Expense of $1.63 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-09.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2014-05-09
- FURIEX PHARMACEUTICALS, INC. interest expense for the quarter ending 2014-03-31 was $1.63M, a 47.91% increase year-over-year.
- FURIEX PHARMACEUTICALS, INC. interest expense for the quarter ending 2013-12-31 was $1.66M, a 48.04% increase year-over-year.
- FURIEX PHARMACEUTICALS, INC. interest expense for the quarter ending 2013-09-30 was $1.11M, a 32.26% increase year-over-year.
- FURIEX PHARMACEUTICALS, INC. interest expense for the quarter ending 2013-06-30 was $1.11M, a 305.47% increase year-over-year.
- FURIEX PHARMACEUTICALS, INC. interest expense for fiscal 2013 was $4.98M, a 98.56% increase from fiscal 2012.
- FURIEX PHARMACEUTICALS, INC. interest expense for fiscal 2012 was $2.51M, a 507.26% increase from fiscal 2011.
- FURIEX PHARMACEUTICALS, INC. interest expense for fiscal 2011 was $413.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2014-03-31 | $1.63M 10-Q · filed 2014-05-09 | $3.29M derived: sum of 2 quarters · filed 2014-05-09 | $4.39M derived: sum of 3 quarters · filed 2014-05-09 | $5.51M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $2.77M derived: sum of 2 quarters · filed 2014-03-17 | $3.88M derived: sum of 3 quarters · filed 2014-03-17 | $4.98M 10-K · filed 2014-03-17 |
| 2013-09-30 | $1.11M 10-Q · filed 2013-11-12 | $2.22M derived: sum of 2 quarters · filed 2013-11-12 | $3.32M 10-Q · filed 2013-11-12 | $4.44M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-06-30 | $1.11M 10-Q · filed 2013-08-08 | $2.21M 10-Q · filed 2013-08-08 | $3.33M derived: sum of 3 quarters · filed 2014-05-09 | $4.17M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-03-31 | $1.10M 10-Q · filed 2014-05-09 | $2.22M derived: sum of 2 quarters · filed 2014-05-09 | $3.06M derived: sum of 3 quarters · filed 2014-05-09 | $3.33M derived: sum of 4 quarters · filed 2014-05-09 |
| 2012-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $1.96M derived: sum of 2 quarters · filed 2014-03-17 | $2.23M derived: sum of 3 quarters · filed 2014-03-17 | $2.51M 10-K · filed 2014-03-17 |
| 2012-09-30 | $837.00K 10-Q · filed 2013-11-12 | $1.11M derived: sum of 2 quarters · filed 2013-11-12 | $1.39M 10-Q · filed 2013-11-12 | $1.66M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $274.00K 10-Q · filed 2013-08-08 | $549.00K 10-Q · filed 2013-08-08 | $826.00K derived: sum of 3 quarters · filed 2014-03-17 | $962.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $275.00K 10-Q · filed 2013-05-09 | $552.00K derived: sum of 2 quarters · filed 2014-03-17 | $688.00K derived: sum of 3 quarters · filed 2014-03-17 | |
| 2011-12-31 | $277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $413.00K derived: sum of 2 quarters · filed 2014-03-17 | $413.00K 10-K · filed 2014-03-17 | |
| 2011-09-30 | $136.00K 10-Q · filed 2012-11-06 | $136.00K 10-Q · filed 2012-11-06 |